FDA may approve COVID-19 drug for 16- and 17-year-olds as soon as next week
The Food and Drug Administration may authorize a COVID-19 booster from Pfizer Inc.
PFE,
and BioNTech SE
BNTX,
for use by 16- and 17-year-olds as soon as next week when there is concern about a new, possibly more contagious variant, according to a person familiar with the plan.
The agency is planning to act quickly on requests from companies to license boosters to 16- and 17-year-olds, according to a person familiar with the matter. So far, only people 18 years or older is eligible for boosters.
https://www.marketwatch.com/story/fda-may-ok-covid-boosters-for-16-and-17-year-olds-as-soon-as-next-week-11638237131?rss=1&siteid=rss FDA may approve COVID-19 drug for 16- and 17-year-olds as soon as next week
